x
Filter:
Filters applied
- Molecular Bases of Disease
- Bellotti, VittorioRemove Bellotti, Vittorio filter
- Mangione, P PatriziaRemove Mangione, P Patrizia filter
Publication Date
Please choose a date range between 2016 and 2020.
Author
- Faravelli, Giulia3
- Giorgetti, Sofia3
- Marchese, Loredana3
- Raimondi, Sara3
- Canetti, Diana2
- Corazza, Alessandra2
- Gillmore, Julian D2
- Pepys, Mark B2
- Relini, Annalisa2
- Stoppini, Monica2
- Taylor, Graham W2
- Valli, Maurizia2
- Verona, Guglielmo2
- Ami, Diletta1
- Canale, Claudio1
- Doglia, Silvia M1
- Esposito, Marilena1
- Hawkins, Philip N1
- Marcoux, Julien1
- Mondani, Valentina1
- Natalello, Antonino1
- Nocerino, Paola1
- Obici, Laura1
Molecular Bases of Disease
3 Results
- Editors' PicksOpen Access
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils
Journal of Biological ChemistryVol. 295Issue 33p11379–11387Published online: June 22, 2020- Sara Raimondi
- P. Patrizia Mangione
- Guglielmo Verona
- Diana Canetti
- Paola Nocerino
- Loredana Marchese
- and others
Cited in Scopus: 9Systemic amyloidosis caused by extracellular deposition of insoluble fibrils derived from the pathological aggregation of circulating proteins, such as transthyretin, is a severe and usually fatal condition. Elucidation of the molecular pathogenic mechanism of the disease and discovery of effective therapies still represents a challenging medical issue. The in vitro preparation of amyloid fibrils that exhibit structural and biochemical properties closely similar to those of natural fibrils is central to improving our understanding of the biophysical basis of amyloid formation in vivo and may offer an important tool for drug discovery. - Molecular Bases of DiseaseOpen Access
Plasminogen activation triggers transthyretin amyloidogenesis in vitro
Journal of Biological ChemistryVol. 293Issue 37p14192–14199Published online: July 17, 2018- P. Patrizia Mangione
- Guglielmo Verona
- Alessandra Corazza
- Julien Marcoux
- Diana Canetti
- Sofia Giorgetti
- and others
Cited in Scopus: 49Systemic amyloidosis is a usually fatal disease caused by extracellular accumulation of abnormal protein fibers, amyloid fibrils, derived by misfolding and aggregation of soluble globular plasma protein precursors. Both WT and genetic variants of the normal plasma protein transthyretin (TTR) form amyloid, but neither the misfolding leading to fibrillogenesis nor the anatomical localization of TTR amyloid deposition are understood. We have previously shown that, under physiological conditions, trypsin cleaves human TTR in a mechano-enzymatic mechanism that generates abundant amyloid fibrils in vitro. - Molecular Bases of DiseaseOpen Access
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS
Journal of Biological ChemistryVol. 291Issue 18p9678–9689Published online: February 26, 2016- Antonino Natalello
- P. Patrizia Mangione
- Sofia Giorgetti
- Riccardo Porcari
- Loredana Marchese
- Irene Zorzoli
- and others
Cited in Scopus: 24The amyloidogenic variant of β2-microglobulin, D76N, can readily convert into genuine fibrils under physiological conditions and primes in vitro the fibrillogenesis of the wild-type β2-microglobulin. By Fourier transformed infrared spectroscopy, we have demonstrated that the amyloid transformation of wild-type β2-microglobulin can be induced by the variant only after its complete fibrillar conversion. Our current findings are consistent with preliminary data in which we have shown a seeding effect of fibrils formed from D76N or the natural truncated form of β2-microglobulin lacking the first six N-terminal residues.